BREAST IMPLANT-ASSOCIATED – ANAPLASTIC LARGE CELL LYMPHOMA
Breast implants are associated with the development of a rare type of cancer of the immune system called Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Information regarding the number of medical device reports of BIA-ALCL can be found on the FDA’s website. Medical Device Reports of Breast Implant-Associated Anaplastic Large Cell Lymphoma | FDA
As of July 2019, scientific literature reports incidence rates of BIA-ALCL from 1 per 3,817 patients to 1 in 30,000 patients. This cancer has been reported more frequently for textured breast implants. BIA-ALCL typically takes several years to develop after implantation, but cases have been reported as early as within one year. Typical symptoms to be aware of months or years after placement of implants may include:
- breast tightness
- pain
- lumps
- swelling of the breast
The treatment for BIA-ALCL involves an operation to remove the implants and the surrounding scar tissue capsule. Based on the stage of the cancer at diagnosis, some patients have required chemotherapy or radiation.
Please make sure to speak with us about any questions or concerns related to this condition.